Private Company Director’s Directors to Watch 2025 highlights 31 significant and diverse directors who have contributed to and will continue to expand ongoing dialogue on board best practices and corporate governance excellence.
Jennifer Lee
Enzyme by Design
Jennifer Lee serves on the boards of Enzyme by Design, How Women Lead and the American Cancer Society’s BrightEdge Entrepreneurs.
A member of Private Directors Association, Lee contributes to the field through thought leadership, publications and advisory roles. With extensive experience in biotech and life sciences, she has driven the growth of organizations by scaling operations, launching innovative therapies and navigating complex regulatory landscapes.
Lee’s work at Pfizer, Gilead, Astellas and Radius Health includes pivotal contributions to multiple FDA approvals of first-in-class therapies and successful exits, solidifying her reputation as a transformative leader in the industry.
Champion innovation and strategic accountability to drive sustainable growth: “Effective boards are vital to balancing innovation, capital and risk to achieve sustainable success. They advocate for financial discipline, strategic planning and measurable results, ensuring resources align with the company’s long-term vision. Cultivating an environment where innovation thrives without compromising accountability is key for fueling growth. Strong governance requires proactive risk management, clear prioritization and resilience to adapt in challenging times. By championing strategic focus and open dialogue, directors enable organizations to navigate uncertainties effectively while driving innovation and ensuring sustainable outcomes that deliver value for stakeholders.”